[Marketwired] - Imprimis Pharmaceuticals, Inc. has taken the first steps in implementing its long-term drug development strategy. On June 17, 2013, Imprimis announced it has acquired rights to certain intellectual property ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment